Sign in
8-K

Current Report

Rani Therapeutics Holdings, Inc. Filed Acc 0000950170-23-057420

Material agreement · Results of operations · Exit or restructuring costs

  • Item 1.01 Entry into a material definitive agreement
  • Item 2.02 Results of operations and financial condition
  • Item 2.05 Costs associated with exit or disposal activities

From the SEC's structured data for this filing

Loading rani-20231101.htm…